Global Trust Asset Management LLC cut its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.0% in the third ...

There isn't any guarantee that the company will be a good investment on the force or direction of those trends alone. But ...

Foundation has awarded Baylor College of Medicine Global Health $2.25 million (about K3.9 billion) for a three-year ...

Equities researchers at Leerink Partnrs decreased their Q3 2024 EPS estimates for Bristol-Myers Squibb in a research report ...

Fintel reports that on October 25, 2024, Citigroup downgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Buy to ...

A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to ...

Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...

A risk stratification algorithm may be able to predict which patients with advanced chronic liver disease are at risk of ...

Bristol Myers Squibb and Ideaya Biosciences both released detailed snapshots of early-stage data for cancer drugs targeting ...

Amgen Inc.'s Q3 earnings may not be a major upside, but new pipeline drugs and potential breakthroughs could drive growth.

Colorectal cancer (CRC) is a type of cancer that begins in the colon or rectum, parts of the large intestine. It is one of the most common cancers worldwide ...

Expectations for Bristol Myers Squibb's Q3 results have significantly declined. Despite this, check out why I maintain a "Buy ...